- Home
- UUU vs KZIA Comparison
UUU vs KZIA Comparison
Compare UUU & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUU
- KZIA
- Stock Information
- Founded
- UUU 1969
- KZIA 1994
- Country
- UUU United States
- KZIA Australia
- Employees
- UUU N/A
- KZIA N/A
- Industry
- UUU Electronic Components
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- UUU Technology
- KZIA Health Care
- Exchange
- UUU Nasdaq
- KZIA Nasdaq
- Market Cap
- UUU 5.4M
- KZIA 6.0M
- IPO Year
- UUU N/A
- KZIA 1999
- Fundamental
- Price
- UUU $1.79
- KZIA $0.80
- Analyst Decision
- UUU
- KZIA Strong Buy
- Analyst Count
- UUU 0
- KZIA 2
- Target Price
- UUU N/A
- KZIA $11.50
- AVG Volume (30 Days)
- UUU 16.4K
- KZIA 334.9K
- Earning Date
- UUU 02-14-2025
- KZIA 04-11-2025
- Dividend Yield
- UUU N/A
- KZIA N/A
- EPS Growth
- UUU N/A
- KZIA N/A
- EPS
- UUU N/A
- KZIA N/A
- Revenue
- UUU $22,168,402.00
- KZIA $1,655,324.00
- Revenue This Year
- UUU N/A
- KZIA N/A
- Revenue Next Year
- UUU N/A
- KZIA N/A
- P/E Ratio
- UUU N/A
- KZIA N/A
- Revenue Growth
- UUU 5.57
- KZIA 248000.00
- 52 Week Low
- UUU $1.11
- KZIA $0.76
- 52 Week High
- UUU $2.47
- KZIA $15.80
- Technical
- Relative Strength Index (RSI)
- UUU 40.65
- KZIA 37.02
- Support Level
- UUU $1.66
- KZIA $0.91
- Resistance Level
- UUU $1.87
- KZIA $1.05
- Average True Range (ATR)
- UUU 0.09
- KZIA 0.08
- MACD
- UUU 0.01
- KZIA -0.00
- Stochastic Oscillator
- UUU 43.33
- KZIA 12.34
About UUU Universal Security Instruments Inc.
Universal Security Instruments Inc is a U.S based manufacturer and distributor of safety and security devices in the Peoples Republic of China . The company markets a line of residential smoke and carbon monoxide alarms under the trade names UNIVERSAL and USI Electric. It also markets products to the electrical distribution trade such as electrical and lighting distributors as well as manufactured housing companies. Its product portfolio consists of smoke and fire alarms, carbon monoxide alarms, multi-gas alarms, universal smoke sensing technology, and plug-in alarms.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.